Sympathetic and parasympathetic hepatic innervation actively influences VLDL triglyceride secretion. In a model of obese Zucker rats, researchers surgically denervated the sympathetic or parasympathetic hepatic nerve. Removing sympathetic innervation reduced VLDL triglyceride secretion and plasma concentrations after 6 weeks, whereas parasympathetic denervation increased plasma levels of total cholesterol, suggesting a novel treatment target.